Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-30 Purchase | 2026-01-02 4:00 pm | Cue Biopharma Inc. | CUE | Sarraf Pasha Director | 323,857 | $0.308 | $99,747 | 323,857 (Direct) | View |
| 2024-12-16 Purchase | 2024-12-18 4:00 pm | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 30,000 | $1.03 | $30,900 | 164,578 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-06-11 5:47 pm | N/A N/A | Cue Biopharma Inc. | CUE | Ray Sumita Chief Legal Compliance Officer | 0 | $0 | 163,768 (Direct) | View |
| 2026-05-30 Option Award | 2026-06-08 4:25 pm | N/A 2036-05-29 | Cue Biopharma Inc. | CUE | Camardo Daniel A. Director | 1,626 | $0 | 1,626 (Direct) | View |
| 2026-05-30 Option Award | 2026-06-02 8:42 pm | N/A 2036-05-29 | Cue Biopharma Inc. | CUE | Meehan Viola Mong Director | 1,626 | $0 | 1,626 (Direct) | View |
| 2026-05-03 Option Award | 2026-05-07 4:00 pm | N/A 2036-05-02 | Cue Biopharma Inc. | CUE | Lin Shao-Lee CHIEF EXECUTIVE OFFICER | 982,611 | $0 | 982,611 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-10 4:00 pm | N/A 2036-04-08 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 200,000 | $0 | 200,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-10 4:00 pm | N/A 2036-04-08 | Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2026-04-09 Option Award | 2026-04-10 4:00 pm | N/A 2036-04-08 | Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Broadfoot Jill Marie Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Morich Frank Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:00 pm | N/A 2036-01-01 | Cue Biopharma Inc. | CUE | Sarraf Pasha Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2025-09-26 Option Award | 2025-12-05 6:54 pm | N/A 2034-07-23 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-09-29 Option Award | 2025-11-25 4:00 pm | N/A 2035-09-28 | Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER | 125,000 | $0 | 125,000 (Direct) | View |
| 2025-09-29 Option Award | 2025-11-25 4:00 pm | N/A 2035-09-28 | Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-09-29 Option Award | 2025-10-02 8:13 pm | N/A 2035-09-28 | Cue Biopharma Inc. | CUE | Azam Usman CHIEF EXECUTIVE OFFICER | 1,875,000 | $0 | 1,875,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:00 pm | N/A 2035-06-03 | Cue Biopharma Inc. | CUE | Broadfoot Jill Marie Director | 48,800 | $0 | 48,800 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | Baker Daniel G. CHIEF DEVELOPMENT OFFICER | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | Warren Lucinda CHIEF BUSINESS OFFICER | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-25 4:00 pm | N/A 2035-03-20 | Cue Biopharma Inc. | CUE | Levisetti Matteo Chief Medical Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2025-03-10 Option Award | 2025-03-12 4:00 pm | N/A 2035-03-09 | Cue Biopharma Inc. | CUE | Sarraf Pasha Director | 48,800 | $0 | 48,800 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:00 pm | N/A 2035-01-01 | Cue Biopharma Inc. | CUE | Verheyen Patrick Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:00 pm | N/A 2035-01-01 | Cue Biopharma Inc. | CUE | Garzone Pamela Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:00 pm | N/A 2035-01-01 | Cue Biopharma Inc. | CUE | Morich Frank Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:00 pm | N/A 2035-01-01 | Cue Biopharma Inc. | CUE | DRISCOLL FREDERICK W Director | 24,400 | $0 | 24,400 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:00 pm | N/A 2035-01-01 | Cue Biopharma Inc. | CUE | Kiener Peter A Director | 24,400 | $0 | 24,400 (Direct) | View |